Dossier
infant brain injuries
Coverage of infant brain injuries in the Nexus archive.
- US biotech firm developing therapies for infant brain injuries plans Hong Kong listing
Axiom Biosciences, a US-based biotech firm developing AI-powered therapies for infant brain injuries, plans a primary Hong Kong IPO targeting $200 million in 2027, with a secondary US listing in 2029.